Andrew Fedoriw

GlaxoSmithKline (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index1.3kcitations39works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(12), Cancer-related gene regulation(10), Genetic Syndromes and Imprinting(9), Prenatal Screening and Diagnostics(5), Genomics and Chromatin Dynamics(4)

Publications39 total

Abstract 4236: Effects of a DNMT1-selective inhibitor on T-cell activity and tumor cells intrinsic pro-inflammatory response
Cancer Research·2025
Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Data from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Data from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
2023Open Access
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Cancer Immunology Research·2022· 30 citedOpen Access
624 Targeting Type I arginine methyltransferases promotes T cell mediated antitumor immune responses
Regular and Young Investigator Award Abstracts·2021Open Access
Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes
UNC Libraries·2021Open Access
An essential role for a mammalian SWI/SNF chromatin-remodeling complex during male meiosis
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2021· 2 citedOpen Access
Nucleolar Association and Transcriptional Inhibition through 5S rDNA in Mammals
UNC Libraries·2020Open Access
Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development
UNC Libraries·2020Open Access
Differentiation-Driven Nucleolar Association of the Mouse Imprinted Kcnq1 Locus
UNC Libraries·2020· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Satyajit Rajapurkar(16), Shane W. O’Brien(16), Terry Magnuson(16), Jenny Laraio(15), Ryan G. Kruger(15), Olena Barbash(15), Helai P. Mohammad(15), Kimberly N. Smitheman(14), Jiakai Hou(14), Christian Sherk(14), Leila J. Williams(14), Guangchun Han(14), Mark T. Bedford(14), Linghua Wang(14), Patrick Hwu(14), Weiyi Peng(14), Yunfei Wang(13), Chunyu Xu(12), Della Yee(7), Leilei Shi(7)